The Bcr-Abl Leukemia Oncogene Activates Jun Kinase and Requires Jun for Transformation

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1995 Dec 5

PMID 8524841

Citations 106

Authors

A B Raitano

J R Halpern

T M Hambuch

C L Sawyers

Affiliations

Soon will be listed here.

Abstract

The leukemogenic tyrosine kinase fusion protein Bcr-Abl activates a Ras-dependent pathway required for transformation. To examine subsequent signal transduction events we measured the effect of Bcr-Abl on two mitogen-activated protein kinase (MAPK) cascades--the extracellular signal-regulated kinase (ERK) pathway and the Jun N-terminal kinase (JNK) pathway. We find that Bcr-Abl primarily activates JNK in fibroblasts and hematopoietic cells. Bcr-Abl enhances JNK function as measured by transcription from Jun responsive promoters and requires Ras, MEK kinase (MAPK/ERK kinase kinase), and JNK to do so. Dominant-negative mutants of c-Jun, which inhibit the endpoint of the JNK pathway, impair Bcr-Abl transforming activity. These findings implicate the JNK pathway in transformation by a human leukemia oncogene.

Citing Articles

A Nucleus-Targeting WT1 Antagonistic Peptide Encapsulated in Polymeric Nanomicelles Combats Refractory Chronic Myeloid Leukemia.

Chen M, Fang X, Du R, Meng J, Liu J, Liu M Pharmaceutics. 2023; 15(9).

PMID: 37765274 PMC: 10534672. DOI: 10.3390/pharmaceutics15092305.

Profiling of miRNAs and their interfering targets in peripheral blood mononuclear cells from patients with chronic myeloid leukaemia.

Wu S, Lai S, Lu X, Lai H, Chen Y, Chen P Front Oncol. 2023; 13:1173970.

PMID: 37476380 PMC: 10356106. DOI: 10.3389/fonc.2023.1173970.

The EMA Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors.

Tesileanu C, Michaleas S, Gonzalo Ruiz R, Mariz S, Fabriek B, van Hennik P Oncologist. 2023; 28(7):628-632.

PMID: 37141403 PMC: 10322123. DOI: 10.1093/oncolo/oyad119.

A customized mass array panel for :: tyrosine kinase domain mutation screening in chronic myeloid leukemia.

Limsuwanachot N, Rerkamnuaychoke B, Niparuck P, Singdong R, Kongruang A, Hirunpatrawong P J Mass Spectrom Adv Clin Lab. 2023; 28:122-132.

PMID: 37128502 PMC: 10148036. DOI: 10.1016/j.jmsacl.2023.04.002.

Ectopic expression of Nav1.7 in spinal dorsal horn neurons induced by NGF contributes to neuropathic pain in a mouse spinal cord injury model.

Fu Y, Sun L, Zhu F, Xia W, Wen T, Xia R Front Mol Neurosci. 2023; 16:1091096.

PMID: 36937049 PMC: 10020601. DOI: 10.3389/fnmol.2023.1091096.

References

Tauchi T, Boswell H, Leibowitz D, Broxmeyer H . Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway. J Exp Med. 1994; 179(1):167-75. PMC: 2191336. DOI: 10.1084/jem.179.1.167. View

Skorski T, Kanakaraj P, Ku D, Nieborowska-Skorska M, Canaani E, Zon G . Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth. J Exp Med. 1994; 179(6):1855-65. PMC: 2191514. DOI: 10.1084/jem.179.6.1855. View

Derijard B, Hibi M, Wu I, Barrett T, Su B, Deng T . JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 1994; 76(6):1025-37. DOI: 10.1016/0092-8674(94)90380-8. View

Afar D, Goga A, McLaughlin J, Witte O, Sawyers C . Differential complementation of Bcr-Abl point mutants with c-Myc. Science. 1994; 264(5157):424-6. DOI: 10.1126/science.8153630. View

Ten Hoeve J, Kaartinen V, Fioretos T, Haataja L, Voncken J, Heisterkamp N . Cellular interactions of CRKL, and SH2-SH3 adaptor protein. Cancer Res. 1994; 54(10):2563-7. View

Kyriakis J, Banerjee P, Nikolakaki E, Dai T, Rubie E, Ahmad M . The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 1994; 369(6476):156-60. DOI: 10.1038/369156a0. View

Schlessinger J . SH2/SH3 signaling proteins. Curr Opin Genet Dev. 1994; 4(1):25-30. DOI: 10.1016/0959-437x(94)90087-6. View

Su B, Jacinto E, Hibi M, Kallunki T, Karin M, Ben-Neriah Y . JNK is involved in signal integration during costimulation of T lymphocytes. Cell. 1994; 77(5):727-36. DOI: 10.1016/0092-8674(94)90056-6. View

Westwick J, Cox A, Der C, Cobb M, Hibi M, Karin M . Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases. Proc Natl Acad Sci U S A. 1994; 91(13):6030-4. PMC: 44131. DOI: 10.1073/pnas.91.13.6030. View

10.

Johnson G . Ras-dependent growth factor regulation of MEK kinase in PC12 cells. Science. 1994; 265(5177):1458-61. DOI: 10.1126/science.8073291. View

11.

Oda T, Heaney C, Hagopian J, Okuda K, Griffin J, Druker B . Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia. J Biol Chem. 1994; 269(37):22925-8. View

12.

Xie W, Fletcher B, Andersen R, Herschman H . v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element. Mol Cell Biol. 1994; 14(10):6531-9. PMC: 359183. DOI: 10.1128/mcb.14.10.6531-6539.1994. View

13.

Reuther G, Fu H, Cripe L, Collier R, Pendergast A . Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family. Science. 1994; 266(5182):129-33. DOI: 10.1126/science.7939633. View

14.

Minden A, Lin A, McMahon M, Derijard B, Davis R, Johnson G . Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science. 1994; 266(5191):1719-23. DOI: 10.1126/science.7992057. View

15.

Sanchez I, Hughes R, Mayer B, Yee K, Woodgett J, Avruch J . Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature. 1994; 372(6508):794-8. DOI: 10.1038/372794a0. View

16.

Yan M, Dai T, Deak J, Kyriakis J, Zon L, Woodgett J . Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature. 1994; 372(6508):798-800. DOI: 10.1038/372798a0. View

17.

Sawyers C, McLaughlin J, Witte O . Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. J Exp Med. 1995; 181(1):307-13. PMC: 2191855. DOI: 10.1084/jem.181.1.307. View

18.

Kabarowski J, Allen P, Wiedemann L . A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells. EMBO J. 1994; 13(24):5887-95. PMC: 395564. DOI: 10.1002/j.1460-2075.1994.tb06934.x. View

19.

Gupta S, Campbell D, Derijard B, Davis R . Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science. 1995; 267(5196):389-93. DOI: 10.1126/science.7824938. View

20.

Hill C, Treisman R . Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell. 1995; 80(2):199-211. DOI: 10.1016/0092-8674(95)90403-4. View